Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin21.7%+0.1pp21.6%+0.1pp21.5%+0.7pp20.8%+0.4pp20.4%0.0pp
Operating margin-7.8%+2.3pp-10.2%+1.3pp-11.5%+1.7pp-13.2%+4.3pp-17.5%+0.8pp
EBITDA margin-4.1%+2.4pp-6.5%+1.5pp-8%+1.7pp-9.7%+4.4pp-14%+1.1pp
Free cash flow margin-22.4%+3.9pp-26.3%+2.2pp-28.4%-18.6pp-9.8%+1.5pp-11.3%+6.1pp
Returns
Return on invested capital-9.4%+0.4pp-9.8%-0.9pp-8.9%+3.1pp-12%+2.8pp-14.8%+1.1pp
Efficiency
Asset turnover0.9×+0.1×0.8×+0.1×0.6×0.0×0.7×0.0×0.7×0.0×
Liquidity
Current ratio5.9×-0.4×6.4×+2.0×4.4×-1.6×5.9×-1.0×-0.1×
Quick ratio5.9×-0.4×6.4×+2.0×4.4×-1.6×5.9×-1.0×-0.1×
Cash ratio2.8×+1.2×1.6×+0.8×0.8×-1.5×2.3×+0.7×1.6×+0.8×
Leverage
Debt-to-equity0.0×0.0×0.0×0.0×0.0×
Debt-to-assets0.0×0.0×0.0×0.0×0.0×
Interest coverage-5.9×-0.5×-5.3×-1.1×-4.3×-0.2×-4.1×+0.7×-4.8×+0.1×
Per Share
Book value per share$3.17-6.8%$3.40-1.0%$3.43+25.1%$2.74-0.2%$2.75-4.0%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Strata Critical Medical, Inc. Class A Common Stock's profit margins?
Strata Critical Medical, Inc. Class A Common Stock (SRTA) runs a 21.7% gross margin and a -7.8% operating margin, with a 21.0% net margin.
Where do Strata Critical Medical, Inc. Class A Common Stock's ratios come from?
Every ratio is computed from Strata Critical Medical, Inc. Class A Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.